The company is specifically leaning into data center construction. For example, Eaton recently agreed to acquire Boyd Thermal ...
Boehringer Ingelheim has reported encouraging Phase II trial results for apecotrep (BI 764198), a potential first-in-class oral TRPC6 inhibitor being developed for primary focal segmental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results